Fischer Medical Ventures opened higher at ₹29.99, compared with its previous close of ₹29.91. During today's session, the stock has traded between ₹29.27 and ₹30.45, with an average traded price of ₹29.96. It is currently showing a sideways intraday trend.
An investment of ₹10,000 made 2 years ago in Fischer Medical Ventures is now worth
₹ 3,873.00
resulting in a loss of
₹ 6,127.00 (61.27%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+0.14 (+0.47%)
Day High
₹30.45
Day Low
₹29.27
Day Open
₹29.99
Prev Close
₹29.91
Volume
3,86,536
Value Traded
₹1.16 Cr
1W Return
-8.38%
1M Return
-16.23%
3M Return
-22.29%
6M Return
-26.42%
1Y Return
-68.99%
Market Cap (₹ Cr.)
1,967
PE Ratio
85.40
PB Ratio
4.28
Dividend Yield
0.17%
ROE
8.11%
ROCE
12.69%
Book Value (₹)
6.99
Face Value (₹)
1.00
EPS (TTM)
0.06
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-8.38%
6 Week
-
1 Month
-16.23%
3 Month
-22.29%
9 Month
-21.31%
Fischer Medical Ventures passes all AGM resolutions with near-unanimous votes
All four AGM resolutions passed with near-unanimous shareholder approval. Dividend of ₹0.05 per share declared for FY26. David Yeow appointed as Independent Director for a five-year term. 61 members participated remotely in the 33rd AGM held via video conferencing.
12 days agoFischer Medical subsidiaries declare ₹16.5 crore in dividends
Time Medical declared ₹6.5 crore dividend for FY26. FlynnCare declared ₹10 crore dividend for FY26. FMV Global approved $1.1 million interim dividend for FY27. Total domestic dividend payout stands at ₹16.5 crore.
15 days agoFischer Medical Ventures approves ₹50 crore rights issue investment in subsidiaries
Fischer Medical Ventures approved ₹50 crore for rights issues in three material subsidiaries. FMV Global Innovation receives the largest tranche at ₹26 crore. Time Medical International Ventures gets ₹11.5 crore; FlynnCare gets ₹12.5 crore. All investments are cash-based and conducted at arm's length.
19 days agoFischer Medical Ventures submits revised investor presentation for September call
Fischer Medical Ventures submitted a revised investor presentation for its September 7, 2026 call. The filing complies with Regulation 30 of SEBI LODR Regulations, 2015. The company integrates Time Medical imaging hardware with FlynnCare AI software. Products include MRI systems up to 7.0T and multi-specialty screening platforms.
26 days agoFischer Medical Ventures infuses ₹59.67 crore promoter capital, expands globally
Promoter group infused ₹59.67 crore, raising stake from 62.15% to 63.08%. Entered Indonesia market in October 2024 with TB detection solution 4T4TB. Installed first open MRI in Philippines at Bulacan Medical Centre in November 2025. Plans to launch 20 AI-powered rehabilitation centers in Malaysia over two years. Subsidiary FlynnCare deployed province-wide digital healthcare model in Catanduanes.
27 days agoFischer Medical Ventures appoints David Yeow as independent director
Fischer Medical Ventures appointed David Yeow as an additional independent director effective September 3, 2026. The 33rd Annual General Meeting is scheduled for September 29, 2026, via video conferencing. Shareholders on record as of September 22, 2026, are eligible for dividends and e-voting rights. The Audit Committee has been reconstituted with seven members following the new appointment.
1mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,382.50 | -1.11% | ₹17,452.38 | 17.97 | -7.65% | |
| ₹629.85 | -1.11% | ₹16,045.82 | -8.24 | -30.25% | |
| ₹579.45 | -2.45% | ₹8,514.48 | 8.41 | +16.36% | |
| ₹593.90 | -1.05% | ₹4,361.91 | 66.65 | +4.83% | |
| ₹384.85 | -0.27% | ₹3,545.65 | 7.53 | -39.06% | |
| ₹77.94 | -1.45% | ₹3,533.89 | 22.41 | +0.00% | |
| ₹210.29 | +2.02% | ₹3,324.89 | -8.34 | -42.56% | |
| ₹632.80 | -1.74% | ₹2,479.69 | 32.20 | +49.00% | |
| ₹561.65 | -3.16% | ₹1,729.59 | 21.94 | +30.94% | |
| ₹140.32 | -0.45% | ₹1,691.60 | -11.20 | -49.50% | |
| ₹479.15 | -2.03% | ₹1,537.59 | 27.85 | +103.42% | |
| ₹124.22 | +0.89% | ₹1,330.27 | 9.54 | +16.59% |
An investment of ₹10,000 made 2 years ago in Fischer Medical Ventures is now worth
₹ 3,873.00
resulting in a loss of
₹ 6,127.00 (61.27%)
Note: Past profits do not guarantee future returns.
